News Focus
News Focus
icon url

DewDiligence

12/06/16 10:25 AM

#206672 RE: DewDiligence #206595

EPVantage comments on Imbruvica’s would-be competitors:

http://epvantage.com/Universal/View.aspx?type=Story&id=675275&isEPVantage=yes
icon url

DewDiligence

01/19/17 10:46 AM

#208198 RE: DewDiligence #206595

ABBV/JNJ—FDA grants accelerated approval for Imbruvica in MZL—a rare form of NHL:

http://finance.yahoo.com/news/u-fda-approves-imbruvica-ibrutinib-120000631.html